These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 29952440
1. Kawasaki Disease - A Review of Treatment and Outcomes in an Irish Paediatric Cohort 2010-14. Flinn AM, Gavin PJ, McMahon CJ, Oslizok P, Butler KM. Ir Med J; 2018 Feb 09; 111(2):691. PubMed ID: 29952440 [Abstract] [Full Text] [Related]
2. Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol. Eleftheriou D, Moraes YC, Purvis C, Pursell M, Morillas MM, Kahn R, Mossberg M, Kucera F, Tulloh R, Standing JF, Swallow V, McCormack R, Herberg J, Levin M, Wan M, Klein N, Connon R, Walker AS, Brogan P. Trials; 2023 Jan 26; 24(1):60. PubMed ID: 36703139 [Abstract] [Full Text] [Related]
3. Kawasaki disease: a comprehensive review of treatment options. Patel RM, Shulman ST. J Clin Pharm Ther; 2015 Dec 26; 40(6):620-5. PubMed ID: 26547265 [Abstract] [Full Text] [Related]
5. Recent advances in the treatment of Kawasaki disease. Weng KP, Ou SF, Lin CC, Hsieh KS. J Chin Med Assoc; 2011 Nov 26; 74(11):481-4. PubMed ID: 22100015 [Abstract] [Full Text] [Related]
6. Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention : A Systematic Review and Meta-analysis. Chen S, Dong Y, Kiuchi MG, Wang J, Li R, Ling Z, Zhou T, Wang Z, Martinek M, Pürerfellner H, Liu S, Krucoff MW. JAMA Pediatr; 2016 Dec 01; 170(12):1156-1163. PubMed ID: 27749951 [Abstract] [Full Text] [Related]
7. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited. Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM. Pediatrics; 2004 Dec 01; 114(6):e689-93. PubMed ID: 15545617 [Abstract] [Full Text] [Related]
10. Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience. Wilson N, Heaton P, Calder L, Nicholson R, Stables S, Gavin R. J Paediatr Child Health; 2004 Dec 01; 40(9-10):524-9. PubMed ID: 15367145 [Abstract] [Full Text] [Related]
11. Management of acute and refractory Kawasaki disease. Tacke CE, Burgner D, Kuipers IM, Kuijpers TW. Expert Rev Anti Infect Ther; 2012 Oct 01; 10(10):1203-15. PubMed ID: 23199405 [Abstract] [Full Text] [Related]
12. Diagnosis, treatment and outcome of Kawasaki disease in an Australian tertiary setting: a review of three years experience. Singh-Grewal D, Wong M, Isaacs D. J Paediatr Child Health; 2005 Oct 01; 41(9-10):495-9. PubMed ID: 16150066 [Abstract] [Full Text] [Related]
13. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children. Wooditch AC, Aronoff SC. Pediatrics; 2005 Oct 01; 116(4):989-95. PubMed ID: 16199713 [Abstract] [Full Text] [Related]
14. Revisiting the role of steroids and aspirin in the management of acute Kawasaki disease. Dhanrajani A, Yeung RSM. Curr Opin Rheumatol; 2017 Sep 01; 29(5):547-552. PubMed ID: 28661936 [Abstract] [Full Text] [Related]
15. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease. Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y. Arch Dis Child; 2008 Feb 01; 93(2):142-6. PubMed ID: 17962370 [Abstract] [Full Text] [Related]
16. Management of Kawasaki disease. Eleftheriou D, Levin M, Shingadia D, Tulloh R, Klein NJ, Brogan PA. Arch Dis Child; 2014 Jan 01; 99(1):74-83. PubMed ID: 24162006 [Abstract] [Full Text] [Related]
20. Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience. Maric LS, Knezovic I, Papic N, Mise B, Roglic S, Markovinovic L, Tesovic G. Rheumatol Int; 2015 Jun 01; 35(6):1053-8. PubMed ID: 25429794 [Abstract] [Full Text] [Related] Page: [Next] [New Search]